DongA ST Co., Ltd. is a South Korean company specializing in the design, development, and manufacturing of advanced semiconductor testing equipment. The company provides solutions for various semiconductor applications, including memory, logic, and mixed-signal devices. With a focus on innovation and technology leadership, DongA ST aims to meet the evolving needs of the global semiconductor industry.

동아ST

Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products and medical devices worldwide. It offers various ethical drugs, including Closerin for active pulmonary and extra-pulmonary tuberculosis; Dulastin and Leucostim for neutropenia in patients receiving myelosuppressive chemotherapy; Eporon for anemia associated with chronic renal failure; Gemcit for non-small cell lung, pancreatic, breast, bladder, and ovarian cancers; Gonadopin for infertility and annovulation; Growtropin II for growth failure due to an inadequate secretion of growth hormone and idiopathic short stature; Mainta for non-small cell lung cancer and malignant pleural mesothelioma; Monotaxel for breast, non-small cell lung, prostate, head, and neck cancers, as well as gastric adenocarcinoma; Motilitone for use in functional dyspepsia treatment; Stillen for the treatment of gastritis; Suganon for diabetes treatment; Terizidone for active pulmonary and extra-pulmonary tuberculosis; and Zydena for erectile dysfunction treatment. The company also provides licensed-in and licensed-out drugs; and medical devices, which cover high technology medical devices, custom made products, and sets of artificial cardiac circuits for use in open-heart surgery. Dong-A ST Co., Ltd. was founded in 1932 and is headquartered in Seoul, South Korea.

1709

COM:DONGA-ST

DongA ST Co., Ltd.

Last Close

74,200.00

25/09 06:30

Market Cap

577.53B

Beta: -

Volume Today

24.00K

Avg: -

Analysis Not Available